Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

Biotechnology Companies

Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDMO
Avid Bioservices Inc
925.1M
10.7x
---
United StatesTECH
Bio-Techne Corp
12.7B
45.2x
+26.71%
United States
42.0B
---
-9.28%
United StatesBNTX
BioNTech SE
39.2B
3.8x
---
United StatesCSBR
Champions Oncology Inc
91.8M
280.1x
---
United StatesCRL
Charles River Laboratories International Inc
10.7B
24.9x
+18.74%
United StatesICLR
ICON PLC
16.4B
35.6x
-13.50%
United StatesIMTX
Immatics NV
827.8M
18.9x
---
United StatesIQV
IQVIA Holdings Inc
39.0B
34.2x
+59.92%
United StatesMRVI
Maravai LifeSciences Holdings Inc
3.2B
5.3x
---
United StatesMRNA
Moderna Inc
66.7B
6.3x
---
United StatesQGEN
Qiagen NV
11.1B
24.2x
+44.61%
United StatesREGN
Regeneron Pharmaceuticals Inc
81.4B
15.8x
+56.36%
United StatesSYNH
Syneos Health Inc
3.5B
12.4x
+1.99%
United StatesVRTX
Vertex Pharmaceuticals Inc
80.0B
24.6x
---
United StatesABCM
Abcam PLC
3.5B
440.9x
---
United StatesABCL
Abcellera Biologics Inc
3.3B
14.4x
---
United StatesACRX
AcelRx Pharmaceuticals Inc
15.0M
0.3x
---
United StatesAPVO
Aptevo Therapeutics Inc
16.5M
3.0x
---
United StatesRCUS
Arcus Biosciences Inc
2.3B
88.2x
---
United StatesAVIR
Atea Pharmaceuticals Inc
388.1M
13.0x
---
United StatesBXRX
Baudax Bio Inc
1.7M
0.8x
---
United StatesBMRN
Biomarin Pharmaceutical Inc
19.0B
258.9x
---
United StatesCBIO
Catalyst Biosciences Inc
16.9M
1.4x
---
United StatesCMRX
Chimerix Inc
189.3M
1.2x
---
United StatesCGEM
Cullinan Oncology Inc
540.6M
5.4x
---
United StatesDVAX
Dynavax Technologies Corp
1.5B
5.8x
---
United StatesEFTR
eFFECTOR Therapeutics Inc
16.3M
2.8x
---
United StatesEXEL
Exelixis Inc
5.4B
17.6x
---
United StatesGBLX
GB Sciences Inc
9.7M
-50.3x
---
United StatesGNFT
Genfit SA
172.8M
5.2x
---
United StatesGMAB
Genmab A/S
30.2B
37.5x
---
United StatesGRFS
Grifols SA
6.8B
81.6x
---
United StatesHALB
Halberd Corp
5.2M
4.3x
---
United StatesHALO
Halozyme Therapeutics Inc
7.6B
37.8x
---
United StatesHUMA
Humacyte Inc
311.4M
9.1x
---
United StatesIONS
Ionis Pharmaceuticals Inc
5.4B
656.7x
---
United StatesIRWD
Ironwood Pharmaceuticals Inc
1.8B
12.6x
---
United StatesITOS
Iteos Therapeutics Inc
679.8M
2.8x
---
United StatesKNSA
Kiniksa Pharmaceuticals Ltd
1.1B
7.7x
---
United StatesLPCN
Lipocine Inc
36.7M
8.9x
---
United StatesMEDP
Medpace Holdings Inc
6.3B
31.3x
+67.16%
United StatesMOLN
Molecular Partners AG
248.4M
1.8x
---
United StatesNBIX
Neurocrine Biosciences Inc
11.6B
207.0x
---
United StatesNWBO
Northwest Biotherapeutics Inc
1.0B
14.1x
---
United StatesNPHC
Nutra Pharma Corp
2.3M
0.5x
---
United StatesOTLC
Oncotelic Therapeutics Inc
19.6M
2.7x
---
United StatesPBYI
Puma Biotechnology Inc
197.2M
19.5x
---
United StatesRBSH
Rebus Holdings Inc
308.5K
0.1x
---
As of 2022-12-07

Biotechnology

The Biotechnology industry consists of companies engaged in the research and development of new drugs, medical devices and procedures. The industry includes the manufacturing and marketing of drugs as a result of direct research and development. The Biotechnology industry excludes drug manufacturers without research and development operations, and advanced medical equipment wholesalers.

Company Strategies

Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.

Company Strategies Table
CompanyDividend Yield
United StatesGRFS
Grifols SA - ADR
8.17%
United StatesAZTA
Azenta Inc
0.68%
United StatesTECH
BIO-TECHNE Corp
0.40%
United StatesCDMO
Avid Bioservices Inc
---
United StatesXOMA
XOMA Corp
---
At 2022-12-07 02:27 AM ET Data delayed at least 15 minutes.